Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-045120
Filing Date
2024-11-13
Accepted
2024-11-13 16:05:16
Documents
1
Period of Report
2024-11-13

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3138
  Complete submission text file 0001493152-24-045120.txt   4544
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Issuer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5850 SAN FELIPE ST. SUITE 500 HOUSTON TX 77057
Business Address
Swaminathan Arun (Reporting) CIK: 0002034346 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41583 | Film No.: 241454016